Obesitat
Obesity Science and Practice
Ultrasound measures of abdominal fat layers correlate with metabolic syndrome features in patients with obesity
Guillem Cuatrecasas · Francisco de Cabo · Maria Josep Coves · Ioana Patrascioiu · Gerardo Aguilar · Sonia March · Mariona Balfegó · Clara Bretxa · Marta Calbo · Gabriel Cuatrecasas · Gloria Aranda · Aida Orois · Isabel Bové · Elena Munoz-Marron · Pilar García-Lorda
Frontiers in Pediatrics
Ultrasound omental fat as a precocious marker of metabolic adiposity in children
Daniel Sánchez-Ruiz, Mònica Peitx, Marta Calbo, Olga Rossell, Laia Dachs, Júlia Bonet, Andrea Jover and Guillem Cuatrecasas
Obesity Facts
Effect of liraglutide in different abdominal fat layers measured by ultrasound. The importance of perirenal fat reduction
Cuatrecasas G, Calbo M, Rossell O, Dachs L, Aguilar-Soler G, Coves M-J, Patrascioiu I, Benito CE, March S, Balfegó M, Cuatrecasas G, Di Gregorio S, Marina I, Garcia-Lorda P, Munoz-Marron E, De Cabo F
Nature.com Scientific Reports
Dapagliflozin added to metformin reduces perirenal fat layer in type 2 diabetic patients with obesity
Guillem Cuatrecasas · Francisco De Cabo · M. José Coves · Ioana Patrascioiu · Gerardo Aguilar · Gabriel Cuatrecasas · Sonia March · Marta Calbo · Olga Rossell · Mariona Balfegó · Camila Benito · Silvana Di Gregorio · Pilar Garcia Lorda · Elena Muñoz
AIDS RESEARCH AND HUMAN RETROVIRUSES
Ultrasound-Based Assessment of Preperitoneal Fat as a Surrogate Marker of Cardiovascular Risk: Comparative Study Between People Living with HIV and Controls
Anna Bonjoch · Francisco de Cabo · Jordi Puig · Núria Perez-Alvarez · Patricia Echeverria · Bonaventura Clotet · Guillem Cuatrecasas · Eugènia Negredo
JMIR MHEALTH AND UHEALTH
Original Paper
Evaluation Criteria for Weight Management Apps: Validation Using a Modified Delphi Process
Noemí Robles, PhD · Elisa Puigdomènech Puig, MSc · Corpus Gómez-Calderón, BA · Francesc Saigí-Rubió, PhD · Guillem Cuatrecasas Cambra, MD · Alberto Zamora, MD, PhD · Montse Moharra, BA · Guillermo Paluzié, MD, PhD · Mariona Balfegó, PhD · Carme Carrion, PhD.
JMIR MHEALTH AND UHEALTH
Review
Assessment of the Efficacy, Safety, and Effectiveness of Weight Control and Obesity Management Mobile Health Interventions: Systematic Review
Elisa Puigdomenech Puig, MSc · Noemí Robles, PhD · Francesc Saigí-Rubió, PhD · Alberto Zamora, MD, PhD · Montse Moharra, BA · Guillermo Paluzie, MD, PhD · Mariona Balfegó, PhD · Guillem Cuatrecasas Cambra, MD · Pilar Garcia-Lorda, MD, PhD · Carme Carrion, PhD
Rev Esp Endocrinol Pediatr 2020; 11 (Suppl 1)
Obesidad severa del adolescente. Complicaciones endocrino-metabólicas y tratamiento médico.
Diego Yeste · Larry Arciniegas · Ramón Vilallonga · Anna Fàbregas · Laura Soler · Eduard Mogas · Ariadna Campos · María Clemente
bmi journal
SECO-SEEDO
Resultados de la implementación de un programa estructurado de ejercicio físico en una consulta de obesidad.
Marc Aguilar · Gerardo Aguilar · Francisco De Cabo · Aida Orois · Laura Tuneu · Maria José Coves · Sònia March · Marta Calbo · Clara Llobet · Guillem Cuatrecasas
International Journal of Obesity
Clinical Research
Prefronto-cerebellar neuromodulation affects appetite in obesity.
Elena M. Marron · Raquel Viejo-Sobera · Guillem Cuatrecasas · Diego Redolar-Ripoll · Pilar García Lorda · Abhishek Datta · Marom Bikson · Greta Magerowski · Miguel Alonso-Alonso
Hipòfisi i hormona del creixement
Endocrine Connections
Research
GH deficiency in patients with spinal cord injury: efficacy/safety of GH replacement, a pilot study
Guillem Cuatrecasas1,2, Hatice Kumru3,4,5, M Josep Coves1 and Joan Vidal3,4,5
1 Endocrinology Department, Hospital Quiron-Teknon, CPEN S.L., Barcelona, Spain
2 Universitat Oberta Catalunya (UOC), Barcelona, Spain
3 Institut Guttmann, Institut Universitari de Neurorehabilitació Adscrit a la UAB, Barcelona, Spain
4 Univ Autònoma de Barcelona, Cerdanyola del Vallès, Spain
5 Fundació Institut d’Investigació en Ciències de la Salut Germans Trias i Pujol, Barcelona, Spain
The Official Journal of the Pituitary Society
Pituitary
GH/IGF1 axis disturbances in the fibromyalgia syndrome: is there a rationale for GH treatment?
G. Cuatrecasas, C. Alegre & F. F. Casanueva
PAINÒ153 (2012) 1382–1389
Growth hormone treatment for sustained pain reduction and improvementin quality of life in severe fibromyalgia
Guillem Cuatrecasas, C. Alegreb, J. Fernandez-Solàc, M.J. Gonzalez, F. Garcia-Fructuoso, V. Poca-Dias, A. Nadal, Gabriel Cuatrecasas, F. Navarro, A. Mera, M. Lage, R. Peinó, F. Casanueva, C. Liñan, G. Sesmilo, M.J. Coves, J.P. Izquierdo, I. Alvarez, E. Granados, M. Puig-Domingo.
Endocrine Care
High Prevalence of Growth Hormone Deficiency inSevere Fibromyalgia Syndromes
G. Cuatrecasas, M. J. Gonzalez, C. Alegre, G. Sesmilo, J. Fernandez-Solà, F. F. Casanueva, F. Garcia-Fructuoso, V. Poca-Dias, J. P. Izquierdo, and M. Puig-Domingo
Endocrinology Department (G.C.), Centro Médico Teknon and Clinica Sagrada Familia, 08022 Barcelona, Spain; Rheumatology Department (M.J.G., C.A.) and Endocrinology Department (G.S.), Institut Universitari Dexeus, 08028 Barcelona, Spain; Internal Medicine Department (J.F.-S.), Hospital Clinic Universitat Barcelona, 08036 Barcelona, Spain; Universidad Santiago Compostela (F.F.C.), 15705 Santiago, Spain; Rheumatology Department (F.G.-F., V.P.-D.), International Centre of Advanced Medicine Clinic, 08017 Barcelona, Spain; Merck Farma y Química (J.P.I.), 08100 Barcelona, Spain; and Endocrinology Department (M.P.-D.), Hospital Clinic Universitat Barcelona, 08036 Barcelona, Spain
